Nutrien's Shares Rise 26% in a Year: What's Behind the Upside?

Nutrien has rallied 25.7% over the past year as record first-half potash volumes of 7.45 million tons, firmer fertilizer pricing and cost discipline strengthen its earnings and free-cash-flow outlook. The company raised 2026 potash-volume guidance to 14.2-14.8 million tons and cut capital-expenditure guidance by $50 million to $1.95-$2.05 billion. First-half potash and nitrogen selling prices rose 13% and 14% year over year, respectively, supporting Potash EBITDA growth of 15% to $1.24 billion and Nitrogen EBITDA growth of 4% to $1.12 billion.

Analysis

NTR's incremental earnings torque is now more exposed to price durability than volume upside: record potash throughput and sub-$60/t controllable costs imply most additional potash pricing drops through to EBITDA, while reduced capex raises near-term FCF conversion. The less appreciated offset is Retail: rising proprietary mix makes earnings less commodity-beta and can protect consolidated margins if fertilizer benchmarks normalize. Over the next 1-3 months, the market will focus on whether raised volume expectations translate into cash conversion rather than working-capital buildup ahead of application seasons.

IPI is the higher-beta read-through, but also the less diversified and more liquidity-sensitive vehicle; a sustained potash-price/volume environment should produce materially greater percentage earnings revisions there than at NTR. Conversely, CF and MOS face different exposures: nitrogen tightness benefits CF but is vulnerable to North American gas-cost inflation, while phosphate gains at MOS can be diluted by sulfur costs. NTR's automation and brownfield emphasis potentially widens its cost advantage without triggering the industry’s historical overbuild cycle, supporting relative multiple resilience over 6-18 months.

The contrarian risk is that favorable affordability itself invites supply response or demand pull-forward, leaving 2027 shipments exposed once channel inventories rebuild. India tender timing, Belarus/Russia export availability, Chinese fertilizer-export policy, and Brazilian planting economics matter more than management's price commentary. Thesis is falsified by sequential potash price erosion combined with elevated producer inventories, Retail EBITDA below the guided range, or capex/working-capital needs absorbing the anticipated FCF uplift.

Key Decisions for Investors

• Initiate a 3-6 month long NTR / short MOS pair, sized beta-neutral: NTR has superior diversification, proprietary Retail margin insulation and lower execution risk; MOS carries greater phosphate-input-cost and commodity-cycle exposure. Target 10-15% relative return; exit if potash benchmarks fall more than 10% sequentially or NTR reduces Retail EBITDA guidance.
• Use IPI only as a tactical 1-3 month high-beta potash expression after confirmation that offshore potash benchmarks and shipment data remain firm; cap position size given concentrated asset and balance-sheet risk. A 15-20% upside is plausible on upward EPS revisions, but stop on a meaningful global shipment downgrade or potash-price break.
• Maintain NTR as the core fertilizer exposure into the next earnings update, but avoid chasing a sharp pre-results rally; add on weakness if FCF guidance is maintained and inventory/receivables do not accelerate. The key catalyst is evidence that lower capex converts earnings improvement into capital returns.
• Set event alerts for Indian potash tenders, China export restrictions, Belarusian/Russian supply normalization, and North American natural-gas spreads. These are the fastest indicators capable of reversing fertilizer-margin assumptions before reported earnings.